Genovis AB, a leading provider of innovative enzyme technologies, today announced it has received an order with a total value of approximately EUR 1 million (SEK 11 million) from a global pharmaceutical company. The order includes material and related services connected to one of Genovis’ proprietary antibody conjugation technology platforms. Genovis’ technology platform will be […]
WALTHAM, Mass. — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced plans to further increase the impact of Thermo Fisher’s proven growth strategy through the use of artificial intelligence (AI) with OpenAI. This collaboration will help to improve the speed and success of drug development, enabling customers to get medicines […]
ROLLE, Switzerland and TOKYO — A.D.A.M. Innovations, Japan’s leading private genetic testing company, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company pioneering data-driven medicine, today announced at ESMO a strategic agreement to bring cutting-edge liquid biopsy genomic testing to the Japanese population. The companies will also partner to commercialize a liquid biopsy companion diagnostic aimed at advancing personalized and […]
Tod White Promoted to President; Justin McAnear Appointed Chief Financial Officer FREMONT, Calif. — Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced key additions to its executive leadership team. These appointments reflect the company’s continued momentum and its commitment to scaling innovation, operational excellence, and strategic growth. The […]
Merck KGaA, Darmstadt, Germany, is well-positioned for the next wave of growth following strategic portfolio streamlining and targeted investments. Strong position in attractive growth markets due to focused high-tech portfolio and targeted investments Process Solutions, the new Rare Diseases portfolio and Semiconductor Solutions to drive up to 80% of future growth Company targets mid-term annual […]
Waltham, MA — We are proud to announce that Advanced Instruments and Nova Biomedical are now officially doing business under a single, unified brand. This is a transformative moment in our journey to deliver greater value to customers across the biopharmaceutical and clinical markets. Starting today we will be also unveiling a refreshed brand identity […]
The Mystra platform, developed over 10 years, offers biopharma partners proven analytical power to turn months of R&D into minutes, dramatically increasing the availability of quality genetic insights and, therefore, the probability of honing in on successful drug candidates BOSTON — Genomics, a science-led techbio company using large-scale genetic information to develop innovative precision healthcare tools […]
Vienna, Austria — Lexogen, a leader in RNA sequencing technologies, announces the launch of the miRVEL Profiling Small RNA-Seq Library Prep Kit, designed to facilitate small RNA research. The innovative kit integrates seamlessly in the miRVEL small RNA sequencing line and helps scientists achieve reliable results faster and with less hands-on work. The miRVEL Profiling […]
OXFORD, England — At the American Society of Human Genetics (ASHG) 2025 industry session on 16th October, Oxford Nanopore Technologies will share its latest developments in enabling translational and clinical human genetics communities to deliver improved insights into mechanisms for disease in one integrated analysis. The team will highlight the unique capabilities of the PromethION in delivering comprehensive whole […]
Jena / Germany – Analytik Jena has expanded its qPCRsoft 6.0 software for the qTOWER iris with an optional module for 21 CFR Part 11 compliance. This enhancement ensures the software now meets the requirements of the U.S. FDA regulation for electronic records and signatures — a crucial step for laboratories operating in regulated environments such as […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
